Get the Stockscreener App
12.09
2.50%
-0.31
Pre-market:
11.96
-0.13
-1.08%
Indivior Plc stock is traded at $12.09, with a volume of 313.83K.
It is down -2.50% in the last 24 hours and up +5.59% over the past month.
Indivior PLC is a specialty and generic drug manufacturing company. The company is focused on the development, manufacture, and sale of prescription drugs for treatment of substance use disorders and other serious mental illnesses. Its products include, Sublocade, Perseris, Suboxone, Opvee among others. The vast majority of Indivior's revenue is generated in the United States, followed by United Kingdom and the rest of the world.
See More
Previous Close:
$12.40
Open:
$12.05
24h Volume:
313.83K
Relative Volume:
0.45
Market Cap:
$1.51B
Revenue:
$1.12B
Net Income/Loss:
$5.00M
P/E Ratio:
1,209.00
EPS:
0.01
Net Cash Flow:
$-383.00M
1W Performance:
-3.28%
1M Performance:
+5.59%
6M Performance:
+18.65%
1Y Performance:
-21.49%
1-Day Range:
$11.72
$12.17
1-Week Range:
$11.72
$12.58
52-Week Range:
$7.33
$23.22
Indivior Plc Stock (INDV) Company Profile
Compare INDV with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
INDV
Indivior Plc
|
12.09 | 1.51B | 1.12B | 5.00M | -383.00M | 0.01 |
|
ZTS
Zoetis Inc
|
165.02 | 74.45B | 9.15B | 2.43B | 2.31B | 5.32 |
|
HLN
Haleon Plc Adr
|
9.49 | 42.91B | 14.26B | 1.55B | 0 | 0.3383 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.24 | 41.98B | 30.27B | 1.93B | 3.45B | 0.6044 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
21.49 | 24.35B | 16.77B | -959.00M | 1.37B | -0.85 |
|
VTRS
Viatris Inc
|
11.96 | 14.28B | 15.05B | -883.30M | 1.89B | -0.74 |
Indivior Plc Stock (INDV) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-23-24 | Initiated | Piper Sandler | Overweight |
| Apr-03-24 | Initiated | Craig Hallum | Buy |
| Jul-13-23 | Initiated | Northland Capital | Outperform |
Indivior Plc Stock (INDV) Latest News
Indivior transitions to US GAAP reporting for investor interest By Investing.com - Investing.com Canada
Indivior Transitions to US GAAP for Enhanced Market Positioning - TipRanks
Madison Avenue Partners Increases Stake in Indivior PLC - TipRanks
Naloxone Market Future Business Opportunities 2025-2032 | - openPR
Objective long/short (INDV) Report - Stock Traders Daily
Indivior Announces Total Voting Rights and Capital Update - TipRanks
Indivior (NASDAQ:INDV) Shares Gap UpTime to Buy? - MarketBeat
Indivior PLC Experiences Change in Major Shareholdings - TipRanks
Indivior Advances Shareholder Value with Share Repurchase - TipRanks
Indivior Executes Share Repurchase Under $100 Million Program - TipRanks
Indivior Insiders Sold US$7.9m Of Shares Suggesting Hesitancy - Simply Wall St
Indivior Announces Share Repurchase and Cancellation - TipRanks
Indivior : NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES ('PDMR') AND PERSONS CLOSELY ASSOCIATED WITH THEM Form 6 K - Marketscreener.com
Indivior Director Acquires Significant Shareholding - TipRanks
Indivior's Motion to Dismiss Suboxone Lawsuits - LawyersandSettlements.com
Indivior CFO steps down from board after discussions with Oaktree Capital - MSN
Indivior CFO steps down amid Oaktree pressure (INDV:NASDAQ) - Seeking Alpha
Indivior reshuffles board under Oaktree pressure - Reuters
Indivior's (INDV) "Buy" Rating Reaffirmed at Jefferies Financial Group - MarketBeat
Indivior appoints new board members, CFO to step down; shares drop - Investing.com
Indivior makes board changes after move to Nasdaq - ShareCast
Indivior PLC Restructures Board to Enhance Shareholder Value - TipRanks
Indivior reshuffles board as CFO exits under Oaktree pressure - Marketscreener.com
Drugmaker Indivior's finance chief Preblick to step down - Marketscreener.com
Indivior Advances Share Repurchase Initiative - TipRanks
Trend Tracker for (INDV) - Stock Traders Daily
Indivior PLC (NASDAQ:INDV) Shares Sold by Barclays PLC - MarketBeat
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Indivior PLC(INDV) Shareholders - The Eastern Progress Online
Representative actions in securities claims: Court of Appeal hears Wirral Council v Indivior PLC/Reckitt Benckiser Group PLC - Stewarts Law
INDV Investors Have Opportunity to Lead Indivior PLC Securities Fraud Lawsuit - The Eastern Progress Online
Naloxone Market Overall Study Report 2024-2031 | EMERGENT, - openPR
Opioid Use Disorder Market: Share, Key Trends, Growth Drivers, - openPR
INDV Investors Have Opportunity to Lead Indivior PLC Securities Fraud Lawsuit with the Schall Law Firm - The Eastern Progress Online
Suboxone Market Key Trends, Segments, and Fastest Growing - openPR
Indivior (LON:INDV) Shares Down 1.2%Should You Sell? - MarketBeat
Indivior PLC Sued for Securities Law ViolationsContact Levi & Korsinsky Before October 1, 2024 to Discuss Your RightsINDV - The Eastern Progress Online
Indivior (LON:INDV) shareholder returns have been enviable, earning 366% in 5 years - Yahoo Finance
Indivior Announces Q3 2024 Financial Results - The Eastern Progress Online
Indivior Announces Q3 2023 Financial Results - GuruFocus.com
Investors Bid To Revive Suboxone Representative Claim - Law360
Indivior Enhances Shareholder Value with Buyback - TipRanks
Reckitt Investors To Test Class-Action Rules In Opioid Case - Law360
XTX Topco Ltd Boosts Position in Indivior PLC (NASDAQ:INDV) - MarketBeat
Indivior Plc Stock (INDV) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.12%
0.89%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):